PMC:7195088 / 28456-28592 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T20","span":{"begin":70,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"g asymptomatic participants; (b) severity rating on a 3-point ordinal scale at day 14.\n• Comparison of remdesivir vs. hydroxychloroquine"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":30,"end":31},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T154","span":{"begin":52,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001577"}],"text":"g asymptomatic participants; (b) severity rating on a 3-point ordinal scale at day 14.\n• Comparison of remdesivir vs. hydroxychloroquine"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T373","span":{"begin":103,"end":113},"obj":"Chemical"},{"id":"T374","span":{"begin":118,"end":136},"obj":"Chemical"}],"attributes":[{"id":"A373","pred":"chebi_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A374","pred":"chebi_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"g asymptomatic participants; (b) severity rating on a 3-point ordinal scale at day 14.\n• Comparison of remdesivir vs. hydroxychloroquine"}